Overview
Alan is France’s leading health insurance technology company and one of Europe’s most ambitious digital health platforms. Founded in 2016 by Jean-Charles Samuelian-Werve and Charles Gorintin, Alan obtained the first new French health insurance license in 30 years — a regulatory achievement that signals the depth of the company’s compliance capabilities and the French government’s openness to digital-native healthcare alternatives. With over 500,000 members and revenues approaching €500 million, Alan has grown from a digital insurance simplifier into a comprehensive healthcare platform encompassing insurance, mental health services, health navigation, and preventive wellness.
Alan’s strategic ambition extends well beyond digitizing existing insurance workflows. The company is building what it calls a “health partner for life” — a platform that combines insurance risk pooling with proactive health management, AI-powered medical navigation, and mental health support. This positions Alan at the intersection of insurtech and digital health, two of the most actively funded sectors in European venture capital. Alan has raised over €500 million from investors including Index Ventures, Temasek, and Coatue Management, achieving a valuation exceeding €2 billion.
France 2030 Funding & Projects
Alan operates in France 2030’s health and digital health axes through multiple connections. The company’s data-driven approach to health management generates insights that support France 2030’s health data objectives — the Health Data Hub, a France 2030-funded initiative, aims to create a national health data infrastructure that companies like Alan can leverage for population health analytics. Alan’s mental health platform aligns with France 2030’s specific investment in mental health services, following the COVID-19 pandemic’s acceleration of mental health awareness and policy priority.
Alan has benefited from the French Tech label and associated government support mechanisms — Bpifrance investment guarantees, French Tech Visa acceleration, and the broader ecosystem support that France 2030 funds through its digital sovereignty axis. The company’s regulatory pathway was cleared partly through government efforts to modernize France’s health insurance market — a structural reform aligned with France 2030’s broader modernization agenda.
Strategic Position
Alan competes with traditional French mutuelles (nonprofit health insurers) that collectively control over 60% of the French complementary health market, as well as digital insurance startups including Luko and Wakam. The traditional mutual sector has significant inertia — employer and union relationships, long-established product structures, and customer loyalty built over decades. Alan’s competitive edge is product simplicity, claims processing speed (typically less than one hour versus days for traditional insurers), and the value-added health services that differentiate its offering from purely financial insurance.
The European expansion opportunity is substantial: France’s complementary health insurance market is approximately €40 billion annually; Germany, Belgium, and Spain have similarly large but underpenetrated digital health insurance markets. Alan launched in Belgium and Spain, testing a model that, if transferable, would make Alan a pan-European health platform rather than a French national champion — a distinction that matters enormously for ultimate exit valuation.
Key Technology & Innovation
Alan’s technology infrastructure centers on its claims processing engine, which handles the full insurance workflow digitally — receipt of medical invoices (via photo), verification, and reimbursement — without human intervention for standard claims. This automated claims processing is 10x faster than traditional insurer workflows and dramatically lower cost, enabling Alan to price competitively while investing in member services that traditional insurers cannot afford.
The company’s health navigation platform uses AI to help members understand their symptoms, identify appropriate healthcare providers, and navigate the French healthcare system — a genuinely useful service given the complexity of France’s two-tier healthcare structure (Assurance Maladie plus complementary insurance). Alan has also built a mental health service integrating licensed therapist access, self-care tools, and crisis support — an expansion into health delivery rather than purely insurance risk management.
Leadership
Jean-Charles Samuelian-Werve serves as CEO and co-founder, bringing a background in technology and entrepreneurship to an industry dominated by actuaries and insurance professionals. His unconventional approach — treating health insurance as a technology product rather than a financial product — has attracted both the venture capital that funded Alan and the regulatory scrutiny that challenged it. Charles Gorintin, co-founder and CTO, builds the technology stack that enables Alan’s operational model.
Competitive Landscape
Traditional French mutuelles (Harmonie Mutuelle, MGEN, Malakoff Humanis) have the customer base but lack Alan’s technology agility. European digital health insurers including Oscar Health (US) and Ottonova (Germany) demonstrate the potential scale of the model but have struggled with profitability. Alan’s French-first strategy with selective European expansion is arguably more capital-efficient than US-based digital health insurers’ growth-at-all-costs approach.
France 2030’s health axis creates a supportive regulatory environment for digital health innovation — the French government has actively pushed health data access, digital prescription, and telemedicine integration that benefit Alan’s platform approach. The risk is regulatory reversal if a traditional insurance sector lobby succeeds in restricting digital-native insurers’ competitive advantages.
Investor Perspective
Alan is pre-IPO with a €2 billion+ valuation established in its most recent funding round. The company’s path to profitability depends on demonstrating that its member health management capabilities reduce claims costs enough to justify the platform investment — a proposition that requires large-scale actuarial data to prove. As the member base scales toward one million, the actuarial dataset becomes large enough to test this hypothesis conclusively.
For investors, Alan represents the France 2030-adjacent digital health bet: not a direct recipient of France 2030 competition grants, but a company whose business model is materially enabled by France 2030’s health data, digital, and healthcare modernization agenda. The IPO pathway — most likely on Euronext Paris — would be a bellwether for France’s digital health sector maturity.